FitzGerald R J, Meisel H
Department of Life Sciences, University of Limerick, Limerick, Ireland.
Br J Nutr. 2000 Nov;84 Suppl 1:S33-7. doi: 10.1017/s0007114500002221.
Numerous casein and whey protein-derived angiotensin-I-converting enzyme (ACE) inhibitory peptides/hydrolysates have been identified. Clinical trials in hypertensive animals and humans show that these peptides/hydrolysates can bring about a significant reduction in hypertension. These peptides/hydrolysates may be classified as functional food ingredients and nutraceuticals due to their ability to provide health benefits i.e. as functional food ingredients in reducing the risk of developing a disease and as nutraceuticals in the prevention/treatment of disease.
已鉴定出许多源自酪蛋白和乳清蛋白的血管紧张素转换酶（ACE）抑制肽/水解产物。在高血压动物和人类中进行的临床试验表明，这些肽/水解产物可显著降低血压。由于它们具有提供健康益处的能力，即作为降低疾病发生风险的功能性食品成分以及作为预防/治疗疾病的营养保健品，这些肽/水解产物可被归类为功能性食品成分和营养保健品。
